Despite the promising results, further studies are needed to better understand the relationship between gut homeostasis, obesity and psoriasis and the pleiotropic role of PDE4 inhibitors in the management of psoriasis as a complex disease. Here, PDE4A is linked to obesity due to melanocortin 4 receptor deficiency.